Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361002738> ?p ?o ?g. }
- W4361002738 endingPage "12" @default.
- W4361002738 startingPage "1" @default.
- W4361002738 abstract "BACKGROUND: Sickle cell anemia is a hereditary globin chain condition that leads to hemolysis and persistent organ damage. Chronic hemolytic anemia, severe acute and chronic pain, and end-organ destruction occur throughout the lifespan of sickle cell anemia. SCD is associated with a higher risk of mortality. Genome editing with CRISPR-associated regularly interspersed short palindromic repeats (CRISPR/Cas9) have therapeutic potential for sickle cell anemia thala. AIM: This research aimed to see if using CRISPR/Cas9 to target β-globin gene is an effective therapeutic and if it has a long-term effect on Sickle Cell Anemia. METHODS: The method used in this study summarizes the article by looking for keywords that have been determined in the title and abstract. The authors used official guidelines from Science Direct, PubMed, Google Scholar, and Journal Molecular Biology to select full-text articles published within the last decade, prioritizing searches within the past 10 years. RESULTS: CRISPR/Cas9-mediated genome editing in clinical trials contributes to α-globin gene deletion correcting β-thalassemia through balanced α- and β-globin ratios and inhibiting disease progression. CONCLUSION: HBB and BCL11A targeting by CRISPR/Cas9 deletion effectively inactivate BCL11A, a repressor of fetal hemoglobin production. However, further research is needed to determine its side effects and safety." @default.
- W4361002738 created "2023-03-30" @default.
- W4361002738 creator A5022704065 @default.
- W4361002738 creator A5031169541 @default.
- W4361002738 creator A5034902309 @default.
- W4361002738 creator A5038409863 @default.
- W4361002738 creator A5051143129 @default.
- W4361002738 creator A5066911298 @default.
- W4361002738 creator A5076924389 @default.
- W4361002738 date "2023-02-05" @default.
- W4361002738 modified "2023-10-17" @default.
- W4361002738 title "A Review of CRISPR Cas9 for SCA: Treatment Strategies and Could Target β-globin Gene and BCL11A Gene using CRISPR Cas9 Prevent the Patient from Sickle Cell Anemia?" @default.
- W4361002738 cites W1855348513 @default.
- W4361002738 cites W1881664604 @default.
- W4361002738 cites W1968165696 @default.
- W4361002738 cites W2005898133 @default.
- W4361002738 cites W2008989169 @default.
- W4361002738 cites W2010758038 @default.
- W4361002738 cites W2012020901 @default.
- W4361002738 cites W2027401034 @default.
- W4361002738 cites W2036308544 @default.
- W4361002738 cites W2045435533 @default.
- W4361002738 cites W2047936494 @default.
- W4361002738 cites W2049129790 @default.
- W4361002738 cites W2052866728 @default.
- W4361002738 cites W2058122189 @default.
- W4361002738 cites W2063148079 @default.
- W4361002738 cites W2064631448 @default.
- W4361002738 cites W2070879341 @default.
- W4361002738 cites W2073377349 @default.
- W4361002738 cites W2086904866 @default.
- W4361002738 cites W2101111741 @default.
- W4361002738 cites W2134881764 @default.
- W4361002738 cites W2155829072 @default.
- W4361002738 cites W2170845283 @default.
- W4361002738 cites W2182456467 @default.
- W4361002738 cites W2185201235 @default.
- W4361002738 cites W2209402024 @default.
- W4361002738 cites W2238351347 @default.
- W4361002738 cites W2278275104 @default.
- W4361002738 cites W2323549005 @default.
- W4361002738 cites W2334263927 @default.
- W4361002738 cites W2335972680 @default.
- W4361002738 cites W2339456402 @default.
- W4361002738 cites W2409992222 @default.
- W4361002738 cites W2513179752 @default.
- W4361002738 cites W2551672460 @default.
- W4361002738 cites W2559643145 @default.
- W4361002738 cites W2562103559 @default.
- W4361002738 cites W2593923181 @default.
- W4361002738 cites W2618333785 @default.
- W4361002738 cites W2768123850 @default.
- W4361002738 cites W2784423079 @default.
- W4361002738 cites W2794460338 @default.
- W4361002738 cites W2802087233 @default.
- W4361002738 cites W2804329776 @default.
- W4361002738 cites W2898244567 @default.
- W4361002738 cites W2899915044 @default.
- W4361002738 cites W2911700566 @default.
- W4361002738 cites W2923636118 @default.
- W4361002738 cites W2941683499 @default.
- W4361002738 cites W2947116880 @default.
- W4361002738 cites W2947823164 @default.
- W4361002738 cites W2954515500 @default.
- W4361002738 cites W2971545858 @default.
- W4361002738 cites W3000458198 @default.
- W4361002738 cites W3010975733 @default.
- W4361002738 cites W3014005795 @default.
- W4361002738 cites W3082585820 @default.
- W4361002738 cites W3093469725 @default.
- W4361002738 cites W3111094104 @default.
- W4361002738 cites W3112179900 @default.
- W4361002738 cites W3120369081 @default.
- W4361002738 cites W3161425918 @default.
- W4361002738 cites W3217251395 @default.
- W4361002738 cites W4211089719 @default.
- W4361002738 cites W4211225058 @default.
- W4361002738 cites W4221081207 @default.
- W4361002738 cites W4247114649 @default.
- W4361002738 cites W4251903243 @default.
- W4361002738 cites W4282927349 @default.
- W4361002738 cites W4283837991 @default.
- W4361002738 cites W4286434492 @default.
- W4361002738 cites W4312376472 @default.
- W4361002738 cites W4312774167 @default.
- W4361002738 doi "https://doi.org/10.3889/oamjms.2023.11435" @default.
- W4361002738 hasPublicationYear "2023" @default.
- W4361002738 type Work @default.
- W4361002738 citedByCount "0" @default.
- W4361002738 crossrefType "journal-article" @default.
- W4361002738 hasAuthorship W4361002738A5022704065 @default.
- W4361002738 hasAuthorship W4361002738A5031169541 @default.
- W4361002738 hasAuthorship W4361002738A5034902309 @default.
- W4361002738 hasAuthorship W4361002738A5038409863 @default.
- W4361002738 hasAuthorship W4361002738A5051143129 @default.
- W4361002738 hasAuthorship W4361002738A5066911298 @default.
- W4361002738 hasAuthorship W4361002738A5076924389 @default.
- W4361002738 hasBestOaLocation W43610027381 @default.